Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 02-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,848 | 7,076 | 6,196 | N/A | 63 |
| Receivables | 88 | 85 | 56 | 0 | 168 |
| Other current assets | 0 | 0 | 0 | 3,406 | 0 |
| TOTAL | $3,983 | $7,243 | $6,291 | $3,431 | $231 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $3,983 | $7,243 | $6,291 | $3,431 | $231 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 462 |
| Accrued Expenses | N/A | N/A | N/A | 246 | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 150 |
| TOTAL | $558 | $1,713 | $307 | $3,492 | $1,293 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $558 | $1,713 | $307 | $3,492 | $1,293 |
| Shareholders' Equity | |||||
| Common Shares | 16,137 | 15,010 | 11,128 | 302 | 1,053 |
| Retained earnings | -14,284 | -11,138 | -6,177 | -453 | -2,143 |
| Other shareholders' equity | 1,573 | 1,658 | 1,033 | 0 | 29 |
| TOTAL | $3,426 | $5,530 | $5,983 | $-61 | $-1,062 |
| Total Liabilities And Equity | $3,983 | $7,243 | $6,291 | $3,431 | $231 |